Compounds > astragaloside a
Page last updated: 2024-09-03

astragaloside a and ER-Negative PR-Negative HER2-Negative Breast Cancer

astragaloside a has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Che, X; Chen, Y; Liu, Y; Mao, D; Wang, H; Wei, L; Ye, X1

Other Studies

1 other study(ies) available for astragaloside a and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Combination of oxymatrine (Om) and astragaloside IV (As) enhances the infiltration and function of TILs in triple-negative breast cancer (TNBC).
    International immunopharmacology, 2023, Volume: 125, Issue:Pt A

    Topics: Animals; Cancer-Associated Fibroblasts; CD8-Positive T-Lymphocytes; Humans; Mice; Triple Negative Breast Neoplasms; Tumor Microenvironment

2023